Cargando...
MicroRNA-based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer
MicroRNAs (miRs) have been causally implicated in the progression and development of a wide variety of cancers. miRs modulate the activity of key cell signaling networks by regulating the translation of pathway component proteins. Thus, the pharmacological targeting of miRs that regulate cancer cell...
Gardado en:
| Publicado en: | Drug Dev Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758903/ https://ncbi.nlm.nih.gov/pubmed/26284568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21270 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|